img

Global Latent Tuberculosis Infection Detection Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Latent Tuberculosis Infection Detection Market Research Report 2024

The main ways to diagnose LTBI are by placing a tuberculin skin test (TST) on the forearm or by getting a TB blood test, in addition to obtaining a chest radiograph (x-ray) if either one of these tests is positive. One-third of the world's population has LTBI. The TB germs are dormant (asleep) in the body.
According to MRAResearch’s new survey, global Latent Tuberculosis Infection Detection market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Latent Tuberculosis Infection Detection market research.
Key companies engaged in the Latent Tuberculosis Infection Detection industry include Abbott, QIAGEN, F. Hoffmann-La Roche Ltd, Sanofi, Oxford Immunotec USA, ARKRAY, Inc. and bioMérieux SA, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Latent Tuberculosis Infection Detection were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Latent Tuberculosis Infection Detection market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Latent Tuberculosis Infection Detection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Abbott
QIAGEN
F. Hoffmann-La Roche Ltd
Sanofi
Oxford Immunotec USA
ARKRAY, Inc.
bioMérieux SA
Segment by Type
Tuberculin Skin Test
Interferon Gamma Release Assays

Segment by Application


Diagnostic Laboratories
Hospitals/Clinics
Academic & Research Institutions
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Latent Tuberculosis Infection Detection report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Latent Tuberculosis Infection Detection Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Tuberculin Skin Test
1.2.3 Interferon Gamma Release Assays
1.3 Market by Application
1.3.1 Global Latent Tuberculosis Infection Detection Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals/Clinics
1.3.4 Academic & Research Institutions
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Latent Tuberculosis Infection Detection Market Perspective (2018-2033)
2.2 Latent Tuberculosis Infection Detection Growth Trends by Region
2.2.1 Global Latent Tuberculosis Infection Detection Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Latent Tuberculosis Infection Detection Historic Market Size by Region (2018-2023)
2.2.3 Latent Tuberculosis Infection Detection Forecasted Market Size by Region (2024-2033)
2.3 Latent Tuberculosis Infection Detection Market Dynamics
2.3.1 Latent Tuberculosis Infection Detection Industry Trends
2.3.2 Latent Tuberculosis Infection Detection Market Drivers
2.3.3 Latent Tuberculosis Infection Detection Market Challenges
2.3.4 Latent Tuberculosis Infection Detection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Latent Tuberculosis Infection Detection Players by Revenue
3.1.1 Global Top Latent Tuberculosis Infection Detection Players by Revenue (2018-2023)
3.1.2 Global Latent Tuberculosis Infection Detection Revenue Market Share by Players (2018-2023)
3.2 Global Latent Tuberculosis Infection Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Latent Tuberculosis Infection Detection Revenue
3.4 Global Latent Tuberculosis Infection Detection Market Concentration Ratio
3.4.1 Global Latent Tuberculosis Infection Detection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Latent Tuberculosis Infection Detection Revenue in 2022
3.5 Latent Tuberculosis Infection Detection Key Players Head office and Area Served
3.6 Key Players Latent Tuberculosis Infection Detection Product Solution and Service
3.7 Date of Enter into Latent Tuberculosis Infection Detection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Latent Tuberculosis Infection Detection Breakdown Data by Type
4.1 Global Latent Tuberculosis Infection Detection Historic Market Size by Type (2018-2023)
4.2 Global Latent Tuberculosis Infection Detection Forecasted Market Size by Type (2024-2033)
5 Latent Tuberculosis Infection Detection Breakdown Data by Application
5.1 Global Latent Tuberculosis Infection Detection Historic Market Size by Application (2018-2023)
5.2 Global Latent Tuberculosis Infection Detection Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Latent Tuberculosis Infection Detection Market Size (2018-2033)
6.2 North America Latent Tuberculosis Infection Detection Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Latent Tuberculosis Infection Detection Market Size by Country (2018-2023)
6.4 North America Latent Tuberculosis Infection Detection Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Latent Tuberculosis Infection Detection Market Size (2018-2033)
7.2 Europe Latent Tuberculosis Infection Detection Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Latent Tuberculosis Infection Detection Market Size by Country (2018-2023)
7.4 Europe Latent Tuberculosis Infection Detection Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Latent Tuberculosis Infection Detection Market Size (2018-2033)
8.2 Asia-Pacific Latent Tuberculosis Infection Detection Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Latent Tuberculosis Infection Detection Market Size by Region (2018-2023)
8.4 Asia-Pacific Latent Tuberculosis Infection Detection Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Latent Tuberculosis Infection Detection Market Size (2018-2033)
9.2 Latin America Latent Tuberculosis Infection Detection Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Latent Tuberculosis Infection Detection Market Size by Country (2018-2023)
9.4 Latin America Latent Tuberculosis Infection Detection Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Latent Tuberculosis Infection Detection Market Size (2018-2033)
10.2 Middle East & Africa Latent Tuberculosis Infection Detection Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Latent Tuberculosis Infection Detection Market Size by Country (2018-2023)
10.4 Middle East & Africa Latent Tuberculosis Infection Detection Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Latent Tuberculosis Infection Detection Introduction
11.1.4 Abbott Revenue in Latent Tuberculosis Infection Detection Business (2018-2023)
11.1.5 Abbott Recent Development
11.2 QIAGEN
11.2.1 QIAGEN Company Detail
11.2.2 QIAGEN Business Overview
11.2.3 QIAGEN Latent Tuberculosis Infection Detection Introduction
11.2.4 QIAGEN Revenue in Latent Tuberculosis Infection Detection Business (2018-2023)
11.2.5 QIAGEN Recent Development
11.3 F. Hoffmann-La Roche Ltd
11.3.1 F. Hoffmann-La Roche Ltd Company Detail
11.3.2 F. Hoffmann-La Roche Ltd Business Overview
11.3.3 F. Hoffmann-La Roche Ltd Latent Tuberculosis Infection Detection Introduction
11.3.4 F. Hoffmann-La Roche Ltd Revenue in Latent Tuberculosis Infection Detection Business (2018-2023)
11.3.5 F. Hoffmann-La Roche Ltd Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Latent Tuberculosis Infection Detection Introduction
11.4.4 Sanofi Revenue in Latent Tuberculosis Infection Detection Business (2018-2023)
11.4.5 Sanofi Recent Development
11.5 Oxford Immunotec USA
11.5.1 Oxford Immunotec USA Company Detail
11.5.2 Oxford Immunotec USA Business Overview
11.5.3 Oxford Immunotec USA Latent Tuberculosis Infection Detection Introduction
11.5.4 Oxford Immunotec USA Revenue in Latent Tuberculosis Infection Detection Business (2018-2023)
11.5.5 Oxford Immunotec USA Recent Development
11.6 ARKRAY, Inc.
11.6.1 ARKRAY, Inc. Company Detail
11.6.2 ARKRAY, Inc. Business Overview
11.6.3 ARKRAY, Inc. Latent Tuberculosis Infection Detection Introduction
11.6.4 ARKRAY, Inc. Revenue in Latent Tuberculosis Infection Detection Business (2018-2023)
11.6.5 ARKRAY, Inc. Recent Development
11.7 bioMérieux SA
11.7.1 bioMérieux SA Company Detail
11.7.2 bioMérieux SA Business Overview
11.7.3 bioMérieux SA Latent Tuberculosis Infection Detection Introduction
11.7.4 bioMérieux SA Revenue in Latent Tuberculosis Infection Detection Business (2018-2023)
11.7.5 bioMérieux SA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Latent Tuberculosis Infection Detection Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Tuberculin Skin Test
Table 3. Key Players of Interferon Gamma Release Assays
Table 4. Global Latent Tuberculosis Infection Detection Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Latent Tuberculosis Infection Detection Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Latent Tuberculosis Infection Detection Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Latent Tuberculosis Infection Detection Market Share by Region (2018-2023)
Table 8. Global Latent Tuberculosis Infection Detection Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Latent Tuberculosis Infection Detection Market Share by Region (2024-2033)
Table 10. Latent Tuberculosis Infection Detection Market Trends
Table 11. Latent Tuberculosis Infection Detection Market Drivers
Table 12. Latent Tuberculosis Infection Detection Market Challenges
Table 13. Latent Tuberculosis Infection Detection Market Restraints
Table 14. Global Latent Tuberculosis Infection Detection Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Latent Tuberculosis Infection Detection Market Share by Players (2018-2023)
Table 16. Global Top Latent Tuberculosis Infection Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Latent Tuberculosis Infection Detection as of 2022)
Table 17. Ranking of Global Top Latent Tuberculosis Infection Detection Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Latent Tuberculosis Infection Detection Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Latent Tuberculosis Infection Detection Product Solution and Service
Table 21. Date of Enter into Latent Tuberculosis Infection Detection Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Latent Tuberculosis Infection Detection Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Latent Tuberculosis Infection Detection Revenue Market Share by Type (2018-2023)
Table 25. Global Latent Tuberculosis Infection Detection Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Latent Tuberculosis Infection Detection Revenue Market Share by Type (2024-2033)
Table 27. Global Latent Tuberculosis Infection Detection Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Latent Tuberculosis Infection Detection Revenue Market Share by Application (2018-2023)
Table 29. Global Latent Tuberculosis Infection Detection Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Latent Tuberculosis Infection Detection Revenue Market Share by Application (2024-2033)
Table 31. North America Latent Tuberculosis Infection Detection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Latent Tuberculosis Infection Detection Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Latent Tuberculosis Infection Detection Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Latent Tuberculosis Infection Detection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Latent Tuberculosis Infection Detection Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Latent Tuberculosis Infection Detection Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Latent Tuberculosis Infection Detection Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Latent Tuberculosis Infection Detection Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Latent Tuberculosis Infection Detection Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Latent Tuberculosis Infection Detection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Latent Tuberculosis Infection Detection Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Latent Tuberculosis Infection Detection Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Latent Tuberculosis Infection Detection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Latent Tuberculosis Infection Detection Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Latent Tuberculosis Infection Detection Market Size by Country (2024-2033) & (US$ Million)
Table 46. Abbott Company Detail
Table 47. Abbott Business Overview
Table 48. Abbott Latent Tuberculosis Infection Detection Product
Table 49. Abbott Revenue in Latent Tuberculosis Infection Detection Business (2018-2023) & (US$ Million)
Table 50. Abbott Recent Development
Table 51. QIAGEN Company Detail
Table 52. QIAGEN Business Overview
Table 53. QIAGEN Latent Tuberculosis Infection Detection Product
Table 54. QIAGEN Revenue in Latent Tuberculosis Infection Detection Business (2018-2023) & (US$ Million)
Table 55. QIAGEN Recent Development
Table 56. F. Hoffmann-La Roche Ltd Company Detail
Table 57. F. Hoffmann-La Roche Ltd Business Overview
Table 58. F. Hoffmann-La Roche Ltd Latent Tuberculosis Infection Detection Product
Table 59. F. Hoffmann-La Roche Ltd Revenue in Latent Tuberculosis Infection Detection Business (2018-2023) & (US$ Million)
Table 60. F. Hoffmann-La Roche Ltd Recent Development
Table 61. Sanofi Company Detail
Table 62. Sanofi Business Overview
Table 63. Sanofi Latent Tuberculosis Infection Detection Product
Table 64. Sanofi Revenue in Latent Tuberculosis Infection Detection Business (2018-2023) & (US$ Million)
Table 65. Sanofi Recent Development
Table 66. Oxford Immunotec USA Company Detail
Table 67. Oxford Immunotec USA Business Overview
Table 68. Oxford Immunotec USA Latent Tuberculosis Infection Detection Product
Table 69. Oxford Immunotec USA Revenue in Latent Tuberculosis Infection Detection Business (2018-2023) & (US$ Million)
Table 70. Oxford Immunotec USA Recent Development
Table 71. ARKRAY, Inc. Company Detail
Table 72. ARKRAY, Inc. Business Overview
Table 73. ARKRAY, Inc. Latent Tuberculosis Infection Detection Product
Table 74. ARKRAY, Inc. Revenue in Latent Tuberculosis Infection Detection Business (2018-2023) & (US$ Million)
Table 75. ARKRAY, Inc. Recent Development
Table 76. bioMérieux SA Company Detail
Table 77. bioMérieux SA Business Overview
Table 78. bioMérieux SA Latent Tuberculosis Infection Detection Product
Table 79. bioMérieux SA Revenue in Latent Tuberculosis Infection Detection Business (2018-2023) & (US$ Million)
Table 80. bioMérieux SA Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Latent Tuberculosis Infection Detection Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Latent Tuberculosis Infection Detection Market Share by Type: 2022 VS 2033
Figure 3. Tuberculin Skin Test Features
Figure 4. Interferon Gamma Release Assays Features
Figure 5. Global Latent Tuberculosis Infection Detection Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Latent Tuberculosis Infection Detection Market Share by Application: 2022 VS 2033
Figure 7. Diagnostic Laboratories Case Studies
Figure 8. Hospitals/Clinics Case Studies
Figure 9. Academic & Research Institutions Case Studies
Figure 10. Latent Tuberculosis Infection Detection Report Years Considered
Figure 11. Global Latent Tuberculosis Infection Detection Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Latent Tuberculosis Infection Detection Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Latent Tuberculosis Infection Detection Market Share by Region: 2022 VS 2033
Figure 14. Global Latent Tuberculosis Infection Detection Market Share by Players in 2022
Figure 15. Global Top Latent Tuberculosis Infection Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Latent Tuberculosis Infection Detection as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Latent Tuberculosis Infection Detection Revenue in 2022
Figure 17. North America Latent Tuberculosis Infection Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Latent Tuberculosis Infection Detection Market Share by Country (2018-2033)
Figure 19. United States Latent Tuberculosis Infection Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Latent Tuberculosis Infection Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Latent Tuberculosis Infection Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Latent Tuberculosis Infection Detection Market Share by Country (2018-2033)
Figure 23. Germany Latent Tuberculosis Infection Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Latent Tuberculosis Infection Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Latent Tuberculosis Infection Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Latent Tuberculosis Infection Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Latent Tuberculosis Infection Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Latent Tuberculosis Infection Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Latent Tuberculosis Infection Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Latent Tuberculosis Infection Detection Market Share by Region (2018-2033)
Figure 31. China Latent Tuberculosis Infection Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Latent Tuberculosis Infection Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Latent Tuberculosis Infection Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Latent Tuberculosis Infection Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Latent Tuberculosis Infection Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Latent Tuberculosis Infection Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Latent Tuberculosis Infection Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Latent Tuberculosis Infection Detection Market Share by Country (2018-2033)
Figure 39. Mexico Latent Tuberculosis Infection Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Latent Tuberculosis Infection Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Latent Tuberculosis Infection Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Latent Tuberculosis Infection Detection Market Share by Country (2018-2033)
Figure 43. Turkey Latent Tuberculosis Infection Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Latent Tuberculosis Infection Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Abbott Revenue Growth Rate in Latent Tuberculosis Infection Detection Business (2018-2023)
Figure 46. QIAGEN Revenue Growth Rate in Latent Tuberculosis Infection Detection Business (2018-2023)
Figure 47. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Latent Tuberculosis Infection Detection Business (2018-2023)
Figure 48. Sanofi Revenue Growth Rate in Latent Tuberculosis Infection Detection Business (2018-2023)
Figure 49. Oxford Immunotec USA Revenue Growth Rate in Latent Tuberculosis Infection Detection Business (2018-2023)
Figure 50. ARKRAY, Inc. Revenue Growth Rate in Latent Tuberculosis Infection Detection Business (2018-2023)
Figure 51. bioMérieux SA Revenue Growth Rate in Latent Tuberculosis Infection Detection Business (2018-2023)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed